Foghorn Therapeutics Inc (FHTX)
$4.83
$-0.09
(-1.83%)
As on 08-Sep-2026 16:00EDT
Market cap
$292 Mln
Revenue (TTM)
$37 Mln
P/E Ratio
--
P/B Ratio
2005.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-4.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1
-
Face value
--
-
Shares outstanding
59,385,315
6 Years Aggregate
CFO
$-75.01 Mln
EBITDA
$-449.67 Mln
Net Profit
$-458.31 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Foghorn Therapeutics Inc (FHTX)
| -10.6 | -20.4 | 29.5 | -16.3 | -13.7 | -18.3 | -- |
|
BSE Sensex*
| -11.5 | -4.5 | 2.0 | -7.2 | 4.0 | 5.2 | 9.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Foghorn Therapeutics Inc (FHTX)
| 14.4 | -26.6 | 1.1 | -72.1 | 12.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Foghorn Therapeutics Inc (FHTX)
|
4.8 | 292.2 | 36.7 | -64.6 | -175.8 | -- | -- | 2,005.3 |
| 85.1 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 75.4 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 57.7 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 108.3 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 351.3 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 116.5 | 9,761.1 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.5 | |
| 534.2 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 590.9 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 | |
| 124.0 | 9,808.7 | 0.0 | -450.1 | -- | -44.6 | -- | 8.4 |
Shareholding Pattern
View DetailsAbout Foghorn Therapeutics Inc (FHTX)
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses... its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer; and diffuse large B-cell lymphoma, as well as various acute myeloid leukemia and myelodysplastic syndrome. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts. Read more
-
President, CEO & Director
Mr. Adrian H. B. Gottschalk
-
President, CEO & Director
Mr. Adrian H. B. Gottschalk
-
Headquarters
Watertown, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Foghorn Therapeutics Inc (FHTX)
What is the current share price of Foghorn Therapeutics Inc (FHTX) Today?
The share price of Foghorn Therapeutics Inc (FHTX) is $4.83 (NASDAQ) as of 08-Sep-2026 16:00 EDT. Foghorn Therapeutics Inc (FHTX) has given a return of -13.72% in the last 3 years.
What is the current PB & PE ratio of Foghorn Therapeutics Inc (FHTX)?
Since, TTM earnings of Foghorn Therapeutics Inc (FHTX) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-4.58 |
-3.13 |
2024 |
-3.41 |
-6.49 |
2023 |
-2.77 |
-3.53 |
2022 |
-2.45 |
2,381.30 |
2021 |
-8.35 |
8.73 |
What is the 52 Week High and Low of Foghorn Therapeutics Inc (FHTX)?
The 52-week high and low of Foghorn Therapeutics Inc (FHTX) are Rs 7.61 and Rs 3.27 as of 09-Sep-2026.
What is the market cap of Foghorn Therapeutics Inc (FHTX)?
Foghorn Therapeutics Inc (FHTX) has a market capitalisation of $ 292 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Foghorn Therapeutics Inc (FHTX)?
Before investing in Foghorn Therapeutics Inc (FHTX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.